Prognosis after IST compared between patients with PNH⁺ and with PNH^-. (A) Overall survival; (B) failure-free survival; (C) incidence of clonal hematologic disorders, including PNH, myelodysplastic syndrome, and acute myelogenous leukemia; and (D) incidence of relapse.